We report a case of an immunocompromised man with monkeypox who experienced disease progression despite timely initiation of tecovirimat and ultimately required utilization of cidofovir and VIGIV for treatment. In immunocompromised patients, monkeypox might present with a more severe course of disease requiring consideration of alternative treatment strategies.
Keywords: brincidofovir; cidofovir; immunosuppression; monkeypox; tecovirimat; vaccinia immune globulin intravenous.
© 2023 Wiley Periodicals LLC.